These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging? Kumar V, Kumar D, Howman-Giles RB, Little DG. Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350 [Abstract] [Full Text] [Related]
13. Influence of the phosphate balance on the activity distribution of 99mTc-hydroxy-methylene diphosphonate. Experimental studies in the mouse. Cronhjort M, Sääf M, Sjöberg HE, Schnell PO, Jacobsson H. Acta Radiol; 1998 Jul; 39(4):427-33. PubMed ID: 9685832 [Abstract] [Full Text] [Related]
16. 177Lu-EDTMP: a potential therapeutic bone agent. Ando A, Ando I, Tonami N, Kinuya S, Kazuma K, Kataiwa A, Nakagawa M, Fujita N. Nucl Med Commun; 1998 Jun; 19(6):587-91. PubMed ID: 10234664 [Abstract] [Full Text] [Related]
17. Role of mineralisation in the uptake of bone-seeking tracers. Leitha T. Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1369. PubMed ID: 16830119 [No Abstract] [Full Text] [Related]
20. 99Tcm-DTPMP as a skeletal scintigraphy agent: distribution in rats in comparison with 99Tcm-MDP. Láznícek M, Láznícková A, Budský F. Nucl Med Commun; 1996 Dec; 17(12):1016-20. PubMed ID: 9004296 [Abstract] [Full Text] [Related] Page: [Next] [New Search]